Literature DB >> 24212439

Influence of time delay on the estimated lung shunt fraction on 99mTc-labeled MAA scintigraphy for 90Y microsphere treatment planning.

Ruth De Gersem1, Geert Maleux, Hubert Vanbilloen, Kristof Baete, Chris Verslype, Karin Haustermans, Alfons Verbruggen, Eric Van Cutsem, Christophe Michel Deroose.   

Abstract

90Y-microspheres therapy is used to treat selected patients with primary or metastatic liver tumors in a safe and effective way. As a preparation for 90Y-microspheres treatment, a 99mTc-macroaggregated albumin (99mTc-MAA) simulation procedure is essential to evaluate particle shunting to the lung or gastrointestinal tract. We investigated the effect of interval between injection of 99mTc-MAA and time of scanning on the lung shunt fraction (LSF). In 4 patients with secondary hepatic malignancies who underwent repeated whole-body scintigraphy up to 5 hours after injection of 99mTc-MAA, a marked change in LSF was observed. It appears that tracer degradation leads to an important overestimation of LSF at later time points. An overestimation of LSF can lead to dose reduction or canceling of the planned 90Y-microspheres treatment. It is concluded that the interval between injection and scanning should be kept as short as possible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24212439     DOI: 10.1097/RLU.0000000000000241

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Biodistribution of 99mTc-MAA on SPECT/CT performed for 90Y radioembolization therapy planning: a pictorial review.

Authors:  J J Bailey; Y Dewaraja; D Hubers; R N Srinivasa; K A Frey
Journal:  Clin Transl Imaging       Date:  2017-09-11

2.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

3.  Review of diagnostic uses of shunt fraction quantification with technetium-99m macroaggregated albumin perfusion scan as illustrated by a case of Osler-Weber-Rendu syndrome.

Authors:  Kabilan Chokkappan; Anbalagan Kannivelu; Sivasubramanian Srinivasan; Suresh Balasubramanian Babut
Journal:  Ann Thorac Med       Date:  2016 Apr-Jun       Impact factor: 2.219

4.  The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity.

Authors:  Tunc Ones; Emel Eryuksel; Feyyaz Baltacioglu; Berrin Ceyhan; Tanju Yusuf Erdil
Journal:  EJNMMI Res       Date:  2017-12-29       Impact factor: 3.138

5.  Lung Metastasis Postradioembolization of Hepatocellular Carcinoma With Tumor in Vein.

Authors:  Harit Kapoor; Sreeja Sanampudi; Joseph Owen; Driss Raissi
Journal:  ACG Case Rep J       Date:  2020-03-02

6.  Segmentation-guided multi-modal registration of liver images for dose estimation in SIRT.

Authors:  Xikai Tang; Esmaeel Jafargholi Rangraz; Richard's Heeren; Walter Coudyzer; Geert Maleux; Kristof Baete; Chris Verslype; Mark J Gooding; Christophe M Deroose; Johan Nuyts
Journal:  EJNMMI Phys       Date:  2022-01-25

Review 7.  Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.

Authors:  Etienne Garin; Yan Rolland; Sophie Laffont; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

8.  The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study.

Authors:  Jonathan D Allred; Jeremy Niedbala; Justin K Mikell; Dawn Owen; Kirk A Frey; Yuni K Dewaraja
Journal:  EJNMMI Res       Date:  2018-06-15       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.